Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion

被引：6
|
作者：
Belizaire, Roger [1 ]
Makar, Robert S. [2 ]
机构：
[1] Brigham & Womens Hosp, Adult Transfus Med, 75 Francis St, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Blood Transfus Serv, GRJ 2233,55 Fruit St, Boston, MA 02114 USA
来源：
TRANSFUSION MEDICINE REVIEWS | 2020年 / 34卷 / 04期
关键词：
Thrombocytopenia; Platelet transfusion; Refractoriness; Infection; Inflammation; VON-WILLEBRAND-FACTOR; HELICOBACTER-PYLORI ERADICATION; FACTOR-CLEAVING PROTEASE; TUMOR-NECROSIS-FACTOR; IN-VIVO; ENDOTHELIAL GLYCOCALYX; AMINOCAPROIC ACID; SEVERE SEPSIS; IMMUNE THROMBOCYTOPENIA; STAPHYLOCOCCUS-AUREUS;
D O I：
10.1016/j.tmrw.2020.09.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Refractoriness to platelet transfusion is a common clinical problem encountered by the transfusion medicine specialist. It is well recognized that most causes of refractoriness to platelet transfusion are not a consequence of alloimmunization to human leukocyte, platelet-specific, or ABO antigens, but are a consequence of platelet sequestration and consumption. This review summarizes the clinical factors that result in platelet refractoriness and highlights recent data describing novel biological mechanisms that contribute to this clinical problem. (C) 2020 Published by Elsevier Inc.
引用
收藏
页码：242 / 249
页数：8
相关论文
共 50 条
  • [41] The platelet antibody analysis in patients with platelet transfusion refractoriness
    中国输血杂志, 2001, (S1) : 361 - 361
  • [42] FETAL PLATELET TRANSFUSIONS IN THE MANAGEMENT OF ALLOIMMUNE THROMBOCYTOPENIA
    WATERS, AH
    IRELAND, R
    MIBASHAN, RS
    MURPHY, MF
    MILLAR, DS
    CHAPMAN, JF
    METCALFE, P
    DEVRIES, LS
    RODECK, CH
    NICOLAIDES, KH
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 323 - 323
  • [43] ANTENATAL TREATMENT OF ALLOIMMUNE THROMBOCYTOPENIA WITH PLATELET TRANSFUSIONS
    KEKOMAKI, R
    AMMALA, P
    BOCK, J
    FLESLAND, O
    NORDHAGEN, R
    OLSSON, I
    ROGNERUD, H
    SHANWELL, A
    TAANING, E
    TERAMO, K
    WESTGREN, M
    WIKMAN, A
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1311 - 1311
  • [44] Alloimmune and Non-Alloimmune Kidney Graft Losses, Improving Our Understanding of Factors Associated with Failure.
    Cosio, F.
    Rodrigo, E.
    El Ters, M.
    Chopra, B.
    Lorenz, E.
    Stegall, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 418 - 418
  • [45] Platelet alloimmunity: The fetal/neonatal alloimmune thrombocytopenia
    Kaplan, C
    VOX SANGUINIS, 2002, 83 : 289 - 291
  • [46] Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
    Zhang, Jing-Cheng
    Ni, Li-Hong
    Tu, Yan
    Hu, Hui-Xian
    FRONTIERS IN MEDICINE, 2023, 10
  • [47] Immune platelet transfusion refractoriness (PTR): Platelet antibody testing and transfusion support
    Pearson, H.
    Grimm, W.
    Moss, J.
    Watson, N.
    Gordon, S.
    Dennington, P. M.
    Dunckley, H.
    VOX SANGUINIS, 2006, 91 : 264 - 264
  • [48] Alloimmune platelet refractoriness: incidence declines, unsolved problems persist
    Brand, A
    TRANSFUSION, 2001, 41 (06) : 724 - 726
  • [49] REFRACTORINESS TO PLATELET TRANSFUSIONS FOR THROMBOCYTOPENIA OF CENTRAL ORIGIN
    NOROL, F
    DOSQUET, P
    BASTIT, D
    BLAISE, D
    BIERLING, P
    IZNARD, F
    LAMY, T
    MARIE, JP
    MERCATELLO, A
    MICLEA, JM
    VEIL, A
    VICARIOT, M
    RENOM, P
    PRAJS, E
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1995, 2 (01) : 37 - 45
  • [50] Immune mechanisms of platelet refractoriness
    Fischetti, F.
    International Journal of Artificial Organs, 1998, 21 (SUPPL. 6): : 103 - 109
12345